Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis from a phase 2b, randomized, controlled trial

被引：0
|
作者：
Guttman-Yassky, Emma [1 ]
Beck, Lisa A. [2 ]
Anderson, Jaclyn K. [3 ]
Hu, Xiaofei [3 ]
Gu, Yihua [3 ]
Teixeira, Henrique D. [3 ]
Silverberg, Jonathan I. [4 ]
机构：
[1] Icahn Sch Med Mt Sinai, Med Ctr, New York, NY 10029 USA
[2] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[3] AbbVie Inc, N Chicago, IL USA
[4] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
8318
引用
收藏
页码：AB294 / AB294
页数：1
相关论文
共 50 条
  • [1] Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial
    Guttman-Yassky, Emma
    Silverberg, Jonathan I.
    Thaci, Diamant
    Papp, Kim A.
    Staender, Sonja
    Beck, Lisa A.
    Kim, Brian S.
    Hu, Xiaofei
    Liu, Jianzhong
    Calimlim, Brian M.
    Vigna, Namita
    Crowley, Jameson T.
    Teixeira, Henrique D.
    Thyssen, Jacob P.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (12) : 2558 - 2568
  • [2] Treatment withdrawal and retreatment with upadacitinib in patients with moderate-to-severe atopic dermatitis from a phase IIb, randomized, controlled trial
    Reich, K.
    Thaci, D.
    Papp, K.
    Anderson, J.
    Hu, X.
    Gu, Y.
    Teixeira, H.
    Guttman-Yassky, E.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (04) : E98 - E99
  • [3] UPADACITINIB EFFECT ON PRURITUS IN MODERATE-TO-SEVERE ATOPIC DERMATITIS; FROM A PHASE 2B RANDOMIZED, PLACEBO-CONTROLLED TRIAL
    Beck, L.
    Hong, C.
    Hu, X.
    Chen, S.
    Calimlim, B.
    Teixeira, H.
    Guttman-Yassky, E.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S21 - S21
  • [4] Early response to upadacitinib in moderate-to-severe atopic dermatitis: Results from a phase 2b randomized, placebo-controlled trial
    Reich, K.
    Guttman-Yassky, E.
    Beck, L. A.
    Hu, X.
    Pangan, A. L.
    Teixeira, H. D.
    ALLERGY, 2018, 73 : 76 - 76
  • [5] Upadacitinib improved patient-reported pruritus in moderate-to-severe atopic dermatitis: results from a phase 2B randomized, placebo-controlled trial
    Hong, C. -H.
    Wu, T.
    Calimlim, B.
    Teixeira, H.
    de Bruin-Weller, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 10 - 10
  • [6] Effectiveness and safety of upadacitinib retreatment after withdrawal in moderate-to-severe atopic dermatitis: a retrospective study
    Hagino, Teppei
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024,
  • [7] Durability of Response to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis After Treatment Discontinuation in a Phase 2b Trial
    Gooderham, Melinda J.
    Girolomoni, Giampiero
    Moore, Julian O.
    Silverberg, Jonathan, I
    Bissonnette, Robert
    Forman, Seth
    Peeva, Elena
    Biswas, Pinaki
    Valdez, Hernan
    Chan, Gary
    DERMATOLOGY AND THERAPY, 2022, 12 (09) : 2077 - 2085
  • [8] Durability of Response to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis After Treatment Discontinuation in a Phase 2b Trial
    Melinda J. Gooderham
    Giampiero Girolomoni
    Julian O. Moore
    Jonathan I. Silverberg
    Robert Bissonnette
    Seth Forman
    Elena Peeva
    Pinaki Biswas
    Hernan Valdez
    Gary Chan
    Dermatology and Therapy, 2022, 12 : 2077 - 2085
  • [9] The effect of dupilumab on biomarkers in a randomized phase 2b clinical trial in adults with moderate-to-severe atopic dermatitis
    Hamilton, J.
    Hamon, S.
    Simpson, E.
    Chaudhry, U.
    Swanson, B.
    Zhang, R.
    Graham, N.
    Pirozzi, G.
    Ardeleanu, M.
    Rizova, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (09) : S224 - S224
  • [10] Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus
    Silverberg, Jonathan, I
    Pinter, Andreas
    Pulka, Grazyna
    Poulin, Yves
    Bouaziz, Jean-David
    Wollenberg, Andreas
    Murrell, Dedee F.
    Alexis, Andrew
    Lindsey, Lisa
    Ahmad, Faiz
    Piketty, Christophe
    Clucas, Alan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (01) : 173 - 182
12345